nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—muscle cancer—bile duct cancer	0.908	1	CtDrD
Methotrexate—ABCC3—bile duct—bile duct cancer	0.00938	0.139	CbGeAlD
Methotrexate—ABCC2—bile duct—bile duct cancer	0.0075	0.111	CbGeAlD
Methotrexate—ABCC2—bile—bile duct cancer	0.00576	0.0854	CbGeAlD
Methotrexate—AOX1—gall bladder—bile duct cancer	0.00205	0.0303	CbGeAlD
Methotrexate—ABCC3—gall bladder—bile duct cancer	0.002	0.0297	CbGeAlD
Methotrexate—GGH—pancreas—bile duct cancer	0.00195	0.0289	CbGeAlD
Methotrexate—ABCC11—liver—bile duct cancer	0.00179	0.0265	CbGeAlD
Methotrexate—ALB—gall bladder—bile duct cancer	0.00171	0.0253	CbGeAlD
Methotrexate—ATIC—pancreas—bile duct cancer	0.00166	0.0246	CbGeAlD
Methotrexate—SLC19A1—liver—bile duct cancer	0.00164	0.0243	CbGeAlD
Methotrexate—SLC46A1—liver—bile duct cancer	0.00126	0.0187	CbGeAlD
Methotrexate—SLC19A1—lymph node—bile duct cancer	0.00126	0.0186	CbGeAlD
Methotrexate—GGH—liver—bile duct cancer	0.00124	0.0184	CbGeAlD
Methotrexate—SLCO4C1—liver—bile duct cancer	0.0011	0.0163	CbGeAlD
Methotrexate—FPGS—liver—bile duct cancer	0.00109	0.0162	CbGeAlD
Methotrexate—SLCO1B3—liver—bile duct cancer	0.00107	0.0159	CbGeAlD
Methotrexate—ATIC—liver—bile duct cancer	0.00106	0.0156	CbGeAlD
Methotrexate—SLC46A1—lymph node—bile duct cancer	0.000967	0.0143	CbGeAlD
Methotrexate—GGH—lymph node—bile duct cancer	0.000951	0.0141	CbGeAlD
Methotrexate—AOX1—pancreas—bile duct cancer	0.000943	0.014	CbGeAlD
Methotrexate—SLC22A11—liver—bile duct cancer	0.000852	0.0126	CbGeAlD
Methotrexate—FPGS—lymph node—bile duct cancer	0.000836	0.0124	CbGeAlD
Methotrexate—SLC22A7—liver—bile duct cancer	0.000832	0.0123	CbGeAlD
Methotrexate—ATIC—lymph node—bile duct cancer	0.000809	0.012	CbGeAlD
Methotrexate—MTHFR—liver—bile duct cancer	0.000784	0.0116	CbGeAlD
Methotrexate—SLCO3A1—liver—bile duct cancer	0.000772	0.0114	CbGeAlD
Methotrexate—ABCC4—pancreas—bile duct cancer	0.000761	0.0113	CbGeAlD
Methotrexate—TYMS—liver—bile duct cancer	0.000716	0.0106	CbGeAlD
Methotrexate—DHFR—liver—bile duct cancer	0.000708	0.0105	CbGeAlD
Methotrexate—PGD—liver—bile duct cancer	0.000681	0.0101	CbGeAlD
Methotrexate—SLCO1C1—lymph node—bile duct cancer	0.000673	0.00997	CbGeAlD
Methotrexate—SLC16A1—liver—bile duct cancer	0.000636	0.00943	CbGeAlD
Methotrexate—SLCO1B1—liver—bile duct cancer	0.000619	0.00917	CbGeAlD
Methotrexate—MTHFR—lymph node—bile duct cancer	0.000601	0.00892	CbGeAlD
Methotrexate—AOX1—liver—bile duct cancer	0.0006	0.0089	CbGeAlD
Methotrexate—SLCO3A1—lymph node—bile duct cancer	0.000592	0.00877	CbGeAlD
Methotrexate—ABCC3—liver—bile duct cancer	0.000587	0.0087	CbGeAlD
Methotrexate—ABCC10—liver—bile duct cancer	0.000584	0.00866	CbGeAlD
Methotrexate—TYMS—lymph node—bile duct cancer	0.000549	0.00814	CbGeAlD
Methotrexate—DHFR—lymph node—bile duct cancer	0.000543	0.00805	CbGeAlD
Methotrexate—PGD—lymph node—bile duct cancer	0.000522	0.00774	CbGeAlD
Methotrexate—SLCO1A2—liver—bile duct cancer	0.000503	0.00746	CbGeAlD
Methotrexate—ALB—liver—bile duct cancer	0.0005	0.00742	CbGeAlD
Methotrexate—SLC16A1—lymph node—bile duct cancer	0.000488	0.00723	CbGeAlD
Methotrexate—ABCC4—liver—bile duct cancer	0.000484	0.00718	CbGeAlD
Methotrexate—ABCC2—liver—bile duct cancer	0.000469	0.00695	CbGeAlD
Methotrexate—AOX1—lymph node—bile duct cancer	0.00046	0.00682	CbGeAlD
Methotrexate—ABCC3—lymph node—bile duct cancer	0.00045	0.00667	CbGeAlD
Methotrexate—ABCC10—lymph node—bile duct cancer	0.000448	0.00664	CbGeAlD
Methotrexate—ABCC1—liver—bile duct cancer	0.000413	0.00613	CbGeAlD
Methotrexate—ALB—lymph node—bile duct cancer	0.000384	0.00569	CbGeAlD
Methotrexate—ABCC4—lymph node—bile duct cancer	0.000371	0.00551	CbGeAlD
Methotrexate—ABCC2—lymph node—bile duct cancer	0.00036	0.00533	CbGeAlD
Methotrexate—ABCG2—liver—bile duct cancer	0.000342	0.00507	CbGeAlD
Methotrexate—ABCC1—lymph node—bile duct cancer	0.000317	0.0047	CbGeAlD
Methotrexate—ABCB1—pancreas—bile duct cancer	0.000265	0.00393	CbGeAlD
Methotrexate—ABCG2—lymph node—bile duct cancer	0.000262	0.00389	CbGeAlD
Methotrexate—ABCB1—liver—bile duct cancer	0.000169	0.0025	CbGeAlD
Methotrexate—ABCB1—lymph node—bile duct cancer	0.000129	0.00192	CbGeAlD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.67e-05	0.00187	CbGpPWpGaD
Methotrexate—DHFR—Disease—IDH1—bile duct cancer	4.62e-05	0.00185	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.59e-05	0.00183	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—FAR2—bile duct cancer	4.58e-05	0.00183	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFBR2—bile duct cancer	4.57e-05	0.00183	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—IDH2—bile duct cancer	4.49e-05	0.0018	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—GNAS—bile duct cancer	4.45e-05	0.00178	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.36e-05	0.00174	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—IDH1—bile duct cancer	4.35e-05	0.00174	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SLC5A5—bile duct cancer	4.35e-05	0.00174	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SMAD4—bile duct cancer	4.33e-05	0.00173	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—IDH1—bile duct cancer	4.25e-05	0.0017	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HGF—bile duct cancer	4.24e-05	0.0017	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFBR2—bile duct cancer	4.18e-05	0.00167	CbGpPWpGaD
Methotrexate—FPGS—Disease—NOS2—bile duct cancer	4.14e-05	0.00165	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—IDH2—bile duct cancer	4.09e-05	0.00164	CbGpPWpGaD
Methotrexate—PGD—Disease—SMAD4—bile duct cancer	3.96e-05	0.00158	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.93e-05	0.00157	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.93e-05	0.00157	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—IDH2—bile duct cancer	3.92e-05	0.00157	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—IDH1—bile duct cancer	3.87e-05	0.00155	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.86e-05	0.00154	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.85e-05	0.00154	CbGpPWpGaD
Methotrexate—ABCC3—NRF2 pathway—TGFB1—bile duct cancer	3.7e-05	0.00148	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.7e-05	0.00148	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—GNAS—bile duct cancer	3.7e-05	0.00148	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—ERBB2—bile duct cancer	3.66e-05	0.00146	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	3.61e-05	0.00144	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—IDH2—bile duct cancer	3.6e-05	0.00144	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—PTGS2—bile duct cancer	3.58e-05	0.00143	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.57e-05	0.00143	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.54e-05	0.00142	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—IDH1—bile duct cancer	3.52e-05	0.00141	CbGpPWpGaD
Methotrexate—ABCC4—NRF2 pathway—TGFB1—bile duct cancer	3.48e-05	0.00139	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.42e-05	0.00137	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.39e-05	0.00135	CbGpPWpGaD
Methotrexate—PGD—Metabolism—GNAS—bile duct cancer	3.38e-05	0.00135	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—IDH1—bile duct cancer	3.37e-05	0.00135	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.34e-05	0.00134	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—GNAS—bile duct cancer	3.32e-05	0.00133	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	3.29e-05	0.00132	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	3.27e-05	0.00131	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS2—bile duct cancer	3.25e-05	0.0013	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—IDH2—bile duct cancer	3.25e-05	0.0013	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS2—bile duct cancer	3.22e-05	0.00129	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.22e-05	0.00129	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HGF—bile duct cancer	3.16e-05	0.00126	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.12e-05	0.00125	CbGpPWpGaD
Methotrexate—FPGS—Disease—ERBB2—bile duct cancer	3.11e-05	0.00124	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—IDH1—bile duct cancer	3.09e-05	0.00124	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.08e-05	0.00123	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.06e-05	0.00122	CbGpPWpGaD
Methotrexate—FPGS—Disease—PTGS2—bile duct cancer	3.04e-05	0.00122	CbGpPWpGaD
Methotrexate—ABCC1—Disease—RNF43—bile duct cancer	3.04e-05	0.00121	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—GNAS—bile duct cancer	3e-05	0.0012	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—PTGS2—bile duct cancer	3e-05	0.0012	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.97e-05	0.00119	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS2—bile duct cancer	2.95e-05	0.00118	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	2.94e-05	0.00117	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.93e-05	0.00117	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.87e-05	0.00115	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC5A5—bile duct cancer	2.87e-05	0.00115	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—bile duct cancer	2.85e-05	0.00114	CbGpPWpGaD
Methotrexate—ALB—Metabolism—FAR2—bile duct cancer	2.83e-05	0.00113	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—IDH2—bile duct cancer	2.83e-05	0.00113	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	2.81e-05	0.00113	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC5A5—bile duct cancer	2.8e-05	0.00112	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—IDH1—bile duct cancer	2.79e-05	0.00112	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NRAS—bile duct cancer	2.78e-05	0.00111	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	2.78e-05	0.00111	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFBR2—bile duct cancer	2.76e-05	0.0011	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	2.75e-05	0.0011	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.71e-05	0.00108	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFBR2—bile duct cancer	2.7e-05	0.00108	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	2.67e-05	0.00107	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.66e-05	0.00106	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SMAD4—bile duct cancer	2.61e-05	0.00104	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IDH1—bile duct cancer	2.61e-05	0.00104	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—bile duct cancer	2.61e-05	0.00104	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFB1—bile duct cancer	2.59e-05	0.00103	CbGpPWpGaD
Methotrexate—AOX1—Disease—SMAD4—bile duct cancer	2.55e-05	0.00102	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TGFB1—bile duct cancer	2.55e-05	0.00102	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC5A5—bile duct cancer	2.55e-05	0.00102	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGS2—bile duct cancer	2.55e-05	0.00102	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGS2—bile duct cancer	2.55e-05	0.00102	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—IDH2—bile duct cancer	2.54e-05	0.00102	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—EGFR—bile duct cancer	2.54e-05	0.00101	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.5e-05	0.001	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	2.5e-05	0.001	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FAR2—bile duct cancer	2.48e-05	0.000991	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFBR2—bile duct cancer	2.45e-05	0.000981	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—bile duct cancer	2.45e-05	0.000979	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—IDH1—bile duct cancer	2.43e-05	0.000972	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	2.43e-05	0.000972	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—bile duct cancer	2.42e-05	0.000969	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—ERBB2—bile duct cancer	2.42e-05	0.000969	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.42e-05	0.000969	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—IDH2—bile duct cancer	2.42e-05	0.000967	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—KRAS—bile duct cancer	2.4e-05	0.000958	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.39e-05	0.000958	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—bile duct cancer	2.37e-05	0.000948	CbGpPWpGaD
Methotrexate—FPGS—Disease—NRAS—bile duct cancer	2.37e-05	0.000947	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC5A5—bile duct cancer	2.32e-05	0.000929	CbGpPWpGaD
Methotrexate—DHFR—Disease—SMAD4—bile duct cancer	2.32e-05	0.000929	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.28e-05	0.00091	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	2.26e-05	0.000903	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—bile duct cancer	2.24e-05	0.000896	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—IDH2—bile duct cancer	2.24e-05	0.000895	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GNAS—bile duct cancer	2.23e-05	0.000892	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC5A5—bile duct cancer	2.23e-05	0.00089	CbGpPWpGaD
Methotrexate—PGD—Disease—ERBB2—bile duct cancer	2.22e-05	0.000886	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—bile duct cancer	2.2e-05	0.00088	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—IDH1—bile duct cancer	2.19e-05	0.000875	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GNAS—bile duct cancer	2.18e-05	0.000871	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—bile duct cancer	2.17e-05	0.000867	CbGpPWpGaD
Methotrexate—FPGS—Disease—EGFR—bile duct cancer	2.16e-05	0.000862	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.11e-05	0.000843	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—IDH1—bile duct cancer	2.08e-05	0.000831	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC5A5—bile duct cancer	2.04e-05	0.000816	CbGpPWpGaD
Methotrexate—FPGS—Disease—KRAS—bile duct cancer	2.04e-05	0.000815	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HRAS—bile duct cancer	2.04e-05	0.000814	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—bile duct cancer	1.98e-05	0.000794	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GNAS—bile duct cancer	1.98e-05	0.000792	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—bile duct cancer	1.95e-05	0.000779	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—bile duct cancer	1.94e-05	0.000778	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—IDH1—bile duct cancer	1.92e-05	0.00077	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.91e-05	0.000765	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—bile duct cancer	1.9e-05	0.00076	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NRAS—bile duct cancer	1.86e-05	0.000744	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NRAS—bile duct cancer	1.84e-05	0.000737	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC5A5—bile duct cancer	1.84e-05	0.000737	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—bile duct cancer	1.82e-05	0.000726	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GNAS—bile duct cancer	1.8e-05	0.000722	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	1.78e-05	0.000712	CbGpPWpGaD
Methotrexate—FPGS—Disease—HRAS—bile duct cancer	1.73e-05	0.000692	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GNAS—bile duct cancer	1.73e-05	0.000691	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—bile duct cancer	1.73e-05	0.000691	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—bile duct cancer	1.73e-05	0.000691	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.73e-05	0.00069	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—bile duct cancer	1.71e-05	0.000685	CbGpPWpGaD
Methotrexate—PGD—Disease—NRAS—bile duct cancer	1.69e-05	0.000674	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EGFR—bile duct cancer	1.68e-05	0.000672	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	1.67e-05	0.000669	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—bile duct cancer	1.66e-05	0.000663	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	1.6e-05	0.000641	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—KRAS—bile duct cancer	1.6e-05	0.00064	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KRAS—bile duct cancer	1.59e-05	0.000635	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GNAS—bile duct cancer	1.59e-05	0.000634	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	1.58e-05	0.00063	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—bile duct cancer	1.57e-05	0.000627	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	1.54e-05	0.000616	CbGpPWpGaD
Methotrexate—PGD—Disease—EGFR—bile duct cancer	1.54e-05	0.000614	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.5e-05	0.000601	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—GNAS—bile duct cancer	1.5e-05	0.000601	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—bile duct cancer	1.47e-05	0.00059	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	1.47e-05	0.000586	CbGpPWpGaD
Methotrexate—MTHFR—Disease—ERBB2—bile duct cancer	1.46e-05	0.000585	CbGpPWpGaD
Methotrexate—PGD—Disease—KRAS—bile duct cancer	1.45e-05	0.00058	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC5A5—bile duct cancer	1.44e-05	0.000577	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GNAS—bile duct cancer	1.43e-05	0.000572	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HGF—bile duct cancer	1.43e-05	0.000572	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—bile duct cancer	1.43e-05	0.000572	CbGpPWpGaD
Methotrexate—AOX1—Disease—ERBB2—bile duct cancer	1.43e-05	0.000571	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—bile duct cancer	1.42e-05	0.000569	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—bile duct cancer	1.4e-05	0.000559	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFBR2—bile duct cancer	1.39e-05	0.000555	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NRAS—bile duct cancer	1.39e-05	0.000555	CbGpPWpGaD
Methotrexate—ALB—Metabolism—IDH2—bile duct cancer	1.38e-05	0.000552	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC5A5—bile duct cancer	1.37e-05	0.000548	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HRAS—bile duct cancer	1.36e-05	0.000544	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.35e-05	0.000541	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HRAS—bile duct cancer	1.35e-05	0.000539	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SMAD4—bile duct cancer	1.31e-05	0.000525	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.3e-05	0.00052	CbGpPWpGaD
Methotrexate—DHFR—Disease—ERBB2—bile duct cancer	1.3e-05	0.00052	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—bile duct cancer	1.29e-05	0.000516	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—bile duct cancer	1.29e-05	0.000515	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—bile duct cancer	1.29e-05	0.000514	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.29e-05	0.000514	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—bile duct cancer	1.27e-05	0.000508	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC5A5—bile duct cancer	1.27e-05	0.000508	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GNAS—bile duct cancer	1.25e-05	0.000498	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—bile duct cancer	1.23e-05	0.000493	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—IDH2—bile duct cancer	1.21e-05	0.000484	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—bile duct cancer	1.2e-05	0.000479	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KRAS—bile duct cancer	1.19e-05	0.000477	CbGpPWpGaD
Methotrexate—ALB—Metabolism—IDH1—bile duct cancer	1.19e-05	0.000475	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—bile duct cancer	1.18e-05	0.000472	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—bile duct cancer	1.17e-05	0.000468	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.14e-05	0.000456	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	1.13e-05	0.000452	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GNAS—bile duct cancer	1.12e-05	0.000448	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	1.11e-05	0.000445	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NRAS—bile duct cancer	1.11e-05	0.000445	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—bile duct cancer	1.1e-05	0.000439	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	1.09e-05	0.000437	CbGpPWpGaD
Methotrexate—AOX1—Disease—NRAS—bile duct cancer	1.09e-05	0.000435	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GNAS—bile duct cancer	1.07e-05	0.000426	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—bile duct cancer	1.06e-05	0.000426	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—bile duct cancer	1.06e-05	0.000424	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—IDH1—bile duct cancer	1.04e-05	0.000416	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—bile duct cancer	1.03e-05	0.000413	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.03e-05	0.000413	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—bile duct cancer	1.01e-05	0.000406	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EGFR—bile duct cancer	1.01e-05	0.000405	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—bile duct cancer	1.01e-05	0.000404	CbGpPWpGaD
Methotrexate—AOX1—Disease—EGFR—bile duct cancer	9.9e-06	0.000396	CbGpPWpGaD
Methotrexate—DHFR—Disease—NRAS—bile duct cancer	9.89e-06	0.000395	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GNAS—bile duct cancer	9.87e-06	0.000395	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—bile duct cancer	9.78e-06	0.000391	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—bile duct cancer	9.69e-06	0.000388	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KRAS—bile duct cancer	9.58e-06	0.000383	CbGpPWpGaD
Methotrexate—AOX1—Disease—KRAS—bile duct cancer	9.35e-06	0.000374	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—bile duct cancer	9.29e-06	0.000371	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—bile duct cancer	9.19e-06	0.000367	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	9.17e-06	0.000367	CbGpPWpGaD
Methotrexate—DHFR—Disease—EGFR—bile duct cancer	9.01e-06	0.00036	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—bile duct cancer	8.52e-06	0.000341	CbGpPWpGaD
Methotrexate—DHFR—Disease—KRAS—bile duct cancer	8.51e-06	0.00034	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—bile duct cancer	8.14e-06	0.000326	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—bile duct cancer	7.95e-06	0.000318	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC5A5—bile duct cancer	7.84e-06	0.000313	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—bile duct cancer	7.79e-06	0.000312	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—bile duct cancer	7.69e-06	0.000307	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—bile duct cancer	7.61e-06	0.000304	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ERBB2—bile duct cancer	7.35e-06	0.000294	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	7.34e-06	0.000294	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—bile duct cancer	7.23e-06	0.000289	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—bile duct cancer	7.19e-06	0.000288	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—bile duct cancer	6.92e-06	0.000277	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC5A5—bile duct cancer	6.87e-06	0.000275	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—bile duct cancer	6.69e-06	0.000268	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NRAS—bile duct cancer	6.27e-06	0.000251	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GNAS—bile duct cancer	6.09e-06	0.000244	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—bile duct cancer	6.02e-06	0.000241	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—bile duct cancer	5.83e-06	0.000233	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—bile duct cancer	5.72e-06	0.000229	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NRAS—bile duct cancer	5.59e-06	0.000224	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KRAS—bile duct cancer	5.4e-06	0.000216	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GNAS—bile duct cancer	5.33e-06	0.000213	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—bile duct cancer	5.3e-06	0.000212	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—bile duct cancer	5.2e-06	0.000208	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EGFR—bile duct cancer	5.1e-06	0.000204	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KRAS—bile duct cancer	4.82e-06	0.000193	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—bile duct cancer	4.8e-06	0.000192	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—bile duct cancer	4.59e-06	0.000184	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—bile duct cancer	4.09e-06	0.000164	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—bile duct cancer	3.92e-06	0.000157	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—bile duct cancer	3.27e-06	0.000131	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—bile duct cancer	2.86e-06	0.000115	CbGpPWpGaD
